SAN DIEGO, June 4, 2015 /PRNewswire/ -- Organovo
Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional
biology company focused on delivering breakthrough 3D bioprinting
technology, announced today that its financial results for the
fiscal year ended March 31, 2015,
will be released Tuesday, June 9,
2015.
The company will host a conference call at 5:00 p.m. Eastern time to discuss the financial
results. If you would like to participate in the call, please
dial-in approximately 10 minutes prior to the start time, and
ask to join the Organovo Holdings, Inc. conference call. The
dial-in info is as follows:
US Toll
Free:
|
1-888-243-4451
|
International
Toll:
|
1-4120542-4135
|
A replay will be made available one hour following the live call
and remain available for 30 days. To access the replay, the dial-in
info is as follows:
US Toll
Free:
|
1-877-344-7529
|
International
Toll:
|
1-412-317-0088
|
Canada Toll
Free:
|
855-669-9658
|
Replay Access
Code:
|
10066930
|
About Organovo Holdings,
Inc.
Organovo designs and creates functional,
three-dimensional human tissues for use in medical research and
therapeutic applications. The Company develops 3D human disease
models through internal development and in collaboration with
pharmaceutical and academic partners. Organovo's 3D human
tissues have the potential to accelerate the drug discovery
process, enabling treatments to be developed faster and at lower
cost. The company recently launched its initial product of the
planned exVive3DTM portfolio offering, a 3D Human
Liver Tissue for use in Toxicology and other preclinical drug
testing. Additional products are in development, with anticipated
release for an exVive3DTM Human Kidney Tissue in
the latter half of calendar year 2016. The Company also actively
conducts early research on specific tissues for therapeutic use in
direct surgical applications. In addition to numerous scientific
publications, the Company's technology has been featured
in The Wall Street Journal, Time Magazine, The Economist,
and numerous other media outlets. Organovo is changing
the shape of medical research and practice. Learn more
at www.organovo.com.
Safe Harbor Statement
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements as that
term is defined in the Private Securities Litigation Reform Act of
1995. Any forward-looking statements contained herein are based on
current expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results
to differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the Company's
ability to develop, market and sell products based on its
technology; the expected benefits and efficacy of the Company's
products and technology; the market acceptance of the Company's
products; and the Company's business, research, product
development, regulatory approval, marketing and distribution plans
and strategies. These and other factors are identified and
described in more detail in our filings with the SEC,
including our Quarterly Report on Form 10-Q filed with
the SEC on February 6, 2015. You should not
place undue reliance on these forward-looking statements, which
speak only as of the date that they were made. These cautionary
statements should be considered with any written or oral
forward-looking statements that we may issue in the future. Except
as required by applicable law, including the securities laws
of the United States, we do
not intend to update any of the forward-looking statements to
conform these statements to reflect actual results, later events or
circumstances or to reflect the occurrence of unanticipated
events.
Sign up for email updates and connect with us
on Twitter (@Organovo).
Logo -
http://photos.prnewswire.com/prnh/20120813/MM55537LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/organovo-holdings-inc-announces-fiscal-year-2015-earnings-conference-call-300094031.html
SOURCE Organovo Holdings, Inc.